Fernando Lozano Vigario
Researcher / Guest
- Name
- F. Lozano Vigario MSc
- Telephone
- +31 71 527 4570
- f.lozano.vigario@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0003-0994-8773
Fernando Lozano Vigario (M.Sc.) is a PhD Student at the Division of Drug Delivery Technology
More information about Fernando Lozano Vigario
Project: Restoring T-cell homeostasis by in vivo manipulation of dendritic cells
Researcher / Guest
- Science
- Leiden Academic Centre for Drug Research
- LACDR/Biopharmaceutics
- Nagy N.A., Lozano Vigario F., Sparrius R., Capel T.M.M. van, Ree R. van, Tas S.W., Vries I.J.M. de, Geijtenbeek T.B.H., Slütter B.A. & Jong E.C. de (2023), Liposomes loaded with vitamin D3 induce regulatory circuits in human dendritic cells, Frontiers in Immunology 14: 1137538.
- Lozano Vigario F., Simo Vesperinas I., Depuydt M.A.C., Bot I., Veelen P. van, Bouwstra J.A., Kros A. & Slutter B. (2023), Immunopeptidomic analysis of human atherosclerosis identifies novel ApoB100-derived antigenic drivers of atherosclerosis, Atherosclerosis 379: S8-S9.
- Depuydt M.A.C., Smit V., Lozano Vigario F., Bernabé Kleijn M.N.A., Vries M.R. de, Quax P.H.A., Wezel A., Smeets H.J., Kuiper J., Foks A.C., Bot I. & Slütter B.A. (2022), Granzyme B+CD4+T cells associate with an unstable plaque phenotype in advanced human atherosclerosis, Cardiovascular Research 118(Supplement_1): cvac066.229.
- Nagy N.A., Castenmiller C., Lozano Vigario F., Sparrius R., Capel T.M.M. van, Haas A.M. de, Kooy Y. van, Ree R. van, Tas S.W., Geijtenbeek T.B.H., Jiskoot W., Slütter B.A. & Jong E.C. de (2022), Uptake kinetics of liposomal formulations of differing charge influences development of in vivo dendritic cell immunotherapy, Journal of Pharmaceutical Sciences 111(4): 1081-1091.
- Lozano Vigario F., Nagy N.A., The M.H., Sparrius R., Bouwstra J.A., Kros A., Jiskoot W., Jong E.C. de & Slütter B.A. (2022), The use of a staggered herringbone micromixer for the preparation of rigid liposomal formulations allows efficient encapsulation of antigen and adjuvant, Journal of Pharmaceutical Sciences 111(4): 1050-1057.
- Keij F.M., Koch B.E.V., Lozano Vigario F., Simons S.H.P., Hasselt J.G.C. van, Knibbe C.A.J., Spaink H.P., Reiss I.K.M. & Krekels E.H.J. (2021), Zebrafish larvae as experimental model to expedite the search for new biomarkers and treatments for neonatal sepsis, Journal of Clinical and Translational Science 5(1): e140.
- Lozano Vigario F. Kuiper J. Slütter B.A. (2020), Tolerogenic vaccines for the treatment of cardiovascular diseases, EBioMedicine 57: 102827.
- Benne N., Leboux R.J.T., Glandrup M., Duijn J. van, Lozano Vigario F., Neustrup M.A., Romeijn S., Galli F., Kuiper J., Jiskoot W. & Slütter B. (2019), Atomic force microscopy measurements of anionic liposomes reveal the effect of liposomal rigidity on antigen-specific regulatory T cell responses, Journal of Controlled Release 318: 246-255.
- Benne N., Duijn J. van, Lozano Vigario F., Leboux R., Veelen P. van, Jiskoot W., Kuiper J. & Slütter B. (2019), Vaccination with a regulatory t-cell inducing vaccine formulation containing apob100 peptides, reduces atherosclerosis in mice, Atherosclerosis 287: e99-e100.
- Benne N., Duijn J. van, Lozano Vigario F.L., Leboux R.J.T., Veelen P. van, Kuiper J., Jiskoot W. & Slütter B. (2018), Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice, Journal of Controlled Release 291: 135-146.
No relevant ancillary activities